High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus. - Wikidata - wikimedia - TriplyDB

High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus.

High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus.

http://www.wikidata.org/entity/Q35557813

about

The role of high mobility group box 1 (HMGB1) in the pathogenesis of kidney diseases Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases Serology of Lupus Erythematosus: Correlation between Immunopathological Features and Clinical Aspects The dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunity Plasma levels of high-mobility group box 1 and soluble receptor for advanced glycation end products in primary antiphospholipid antibody syndrome patients.Coherent somatic mutation in autoimmune disease.The Pathogenesis of Lupus Nephritis.High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus.HMGB1 in health and disease.Impact of serum high mobility group box 1 and soluble receptor for advanced glycation end-products on subclinical atherosclerosis in patients with granulomatosis with polyangiitis.Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis High mobility group box 1 levels in large vessel vasculitis are not associated with disease activity but are influenced by age and statins HMGB1 Is Involved in IFN-α Production and TRAIL Expression by HIV-1-Exposed Plasmacytoid Dendritic Cells: Impact of the Crosstalk with NK Cells Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis HMGB1 May Be a Biomarker for Predicting the Outcome in Patients with Polymyositis /Dermatomyositis with Interstitial Lung Disease.Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus The role of high mobility group box chromosomal protein 1 expression in the differential diagnosis of hepatic actinomycosis: a case report Mannose binding lectin: a biomarker of systemic lupus erythematosus disease activity.Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations.Treatment with anti-HMGB1 monoclonal antibody does not affect lupus nephritis in MRL/lpr mice.Serum HMGB1 Serves as a Novel Laboratory Indicator Reflecting Disease Activity and Treatment Response in Ankylosing Spondylitis Patients.Double-stranded RNA induces inflammation via the NF-κB pathway and inflammasome activation in the outer root sheath cells of hair follicles.Is serum HMGB1 a biomarker in ANCA-associated vasculitis?The influence of cathelicidin LL37 in human anti-neutrophils cytoplasmic antibody (ANCA)-associated vasculitis.HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease.TLR7 and TLR9 in SLE: when sensing self goes wrong.Antinuclear antibodies in rheumatic disease: a proposal for a function-based classification.Cardiovascular disease and high-mobility group box 1--is a new inflammatory killer in town?The alarmin functions of high-mobility group box-1 and IL-33 in the pathogenesis of systemic lupus erythematosus.Recent developments in the role of high-mobility group box 1 in systemic lupus erythematosus.High-mobility group box-1 in sterile inflammation.Association of anti-CLIC2 and anti-HMGB1 autoantibodies with higher disease activity in systemic lupus erythematosus patients.HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins Distinguishing infections vs flares in patients with systemic lupus erythematosus.Members of the receptor for advanced glycation end products axis as potential therapeutic targets in patients with lupus nephritis.Simultaneous changes in serum HMGB1 and IFN-α levels and in LAIR-1 expression on plasmatoid dendritic cells of patients with juvenile SLE. New therapeutic options?High mobility group box 1 skews macrophage polarization and negatively influences phagocytosis of apoptotic cells.HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Isorders (HAND).HMGB1 expression and muscle regeneration in idiopathic inflammatory myopathies and degenerative joint diseases.The western-type diet induces anti-HMGB1 autoimmunity in Apoe(-/-) mice.

P2860

Q26749818-63FF0AD1-0A12-44EB-BB95-4F77EE99537B Q26768480-907DE61E-7B3C-496B-8B09-814BA23EDDA2 Q27023280-979AF099-0BBF-4177-8D96-C64962F8FFDF Q28384138-E7A9E2F9-9E6D-43CA-8568-9332E4BBE14D Q33739280-8C117121-C19F-4EF3-95EC-C1EA700F58F0 Q33837769-3091D5CB-E1A6-4227-B2CE-B0A2BB1D954B Q34040376-36A7E898-5859-4D39-810F-264A15A6ABAB Q34203942-DA3A439A-B246-43C1-86D1-390D2F6049DA Q34622835-39D07192-E7F6-473A-ACAE-4CBBD3522D76 Q35158943-4BEEF368-B80C-4546-A03B-67E48D9632DB Q35177161-CA85F5B0-9E16-44AB-AF52-6C9B462A545B Q35782029-B2CF8E19-089F-4EA9-BC48-3E2EFC449FAE Q35922101-916FC0F2-8222-40A9-8582-C7906B19A7FB Q36085036-8E85FC99-3E05-4F3E-81CA-E8220129D233 Q36106996-F9066E9F-5EEF-4C88-A828-282BA278B7FB Q36310689-1A41B5A8-53C6-46B0-AD69-5C5A07227386 Q36614336-45741CC7-FCCA-475E-B980-F21C8C1F6022 Q36633215-F5B66484-102F-460D-BFCF-18421E4FB450 Q36633397-DB1E6AAB-2915-4DD6-8ADA-3099E289A136 Q37217002-09DEFC00-B7D0-45E4-B578-52CEB539812B Q37348534-95565E34-86BF-4838-A650-919D112F7B29 Q37683948-C223F472-BEDF-46BD-8353-2B0D877837D3 Q37690507-D4264439-09DD-4C85-97DB-68945C5AC782 Q37690925-2B62B547-6DC9-4B4E-A318-69BC3C7F5243 Q37980335-28D4E5E3-F1FF-4698-BFC9-92BEACEEB527 Q37995556-B2C19BC6-78EB-4F32-AD58-FE730AFCA47A Q38016455-40201F7A-C8F6-4231-A362-DDBFEB866F48 Q38040046-B2966BC9-286A-4BC9-86AB-11087D2BF606 Q38131032-3FE62400-3B54-4D1A-B7E1-2D77AAA354CE Q38188456-427BAB25-B7B6-49F1-BCF8-9F8594870B75 Q38220792-49E319F9-54AA-4393-A0BD-FCAA87DF5514 Q38598212-C82DA831-B1BB-4803-9210-88030D70BCD5 Q38939435-485829ED-29A6-4E05-977E-84688C91B6D8 Q38981689-43A66C9F-58E1-44C3-9569-C9C9A3453C7B Q39095935-9221A8DA-1C0C-4CEF-92AA-92DDF998702B Q39277686-74740B34-FBE7-4080-AAD2-14C80A866235 Q39385492-79F0467D-65F4-446F-8D70-0B6169D8AA73 Q40322637-D0878680-C887-4EE0-90AB-1ADBF070CE53 Q41243946-A52931B9-B4B2-4633-9DF4-5C261F2296B7 Q41767127-A25C5D89-EB89-4DDF-9914-ADB36B994702

P2860

High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus.

http://www.wikidata.org/entity/Q35557813

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

High mobility group box 1 (HMG ...... systemic lupus erythematosus.

@ast

High mobility group box 1 (HMG ...... systemic lupus erythematosus.

@en

type

label

High mobility group box 1 (HMG ...... systemic lupus erythematosus.

@ast

High mobility group box 1 (HMG ...... systemic lupus erythematosus.

@en

prefLabel

High mobility group box 1 (HMG ...... systemic lupus erythematosus.

@ast

High mobility group box 1 (HMG ...... systemic lupus erythematosus.

@en

P1433

Q35557813-6734134F-5154-49F5-86C4-00360B4F77C3

P1476

Q35557813-55DBCEF8-593D-4994-AD84-88A14D4C8B94

P2093

Q35557813-19F3DCEE-7533-4655-8191-C183413046F4

Q35557813-2B38782F-9C51-4A8E-81EA-0C8A3F1C0E8E

Q35557813-34E8F585-46A4-4DAE-A597-2E82483ABDF4

Q35557813-57934CD1-DAEE-4A3D-A4D7-5D1DC4914881

Q35557813-71EEB114-A8E4-4ABA-9538-2894B2110A4E

P2860

Q35557813-099902ED-C573-48A2-ACDA-293241C645D3

Q35557813-116276A4-83BD-4CD8-9C11-D45B0FD0A29E

Q35557813-12CF2F17-24B1-439E-8C09-C25C386E0124

Q35557813-15228469-A5C1-4359-B479-3A5079A0FF25

Q35557813-175D7C97-9ABD-4D0B-8F50-8E18369C52BB

Q35557813-1D1B4810-521F-45F1-BBEB-B6E5856D7C6B

Q35557813-1ED244C9-EE91-410F-97BB-0F82696FCF1D

Q35557813-2E613357-47F0-4D37-9C24-BDF708ED9E83

Q35557813-3B09ABD1-6B24-41C3-82BD-8D018E19FF2C

Q35557813-493C5250-830C-4871-BCC7-1B6B2002F50A

P2888

Q35557813-4E721AA3-9CDF-4B23-908F-ABF963A88777

P304

Q35557813-B19DB758-99AE-4F09-BCF7-4F36332FE39E

P31

Q35557813-6AD3959A-C5F7-4DDD-A179-C83518A135FD

P356

Q35557813-CFA86511-70D8-4544-A0DB-6F00073D9E44

P433

Q35557813-EFE25495-028B-444C-BEAE-BC9F571D66AA

P478

Q35557813-F29B914B-A1F1-47B8-BA8B-45C1FFCA35C4

P50

Q35557813-85EC3BC7-99D1-4993-BC1A-CCD54283D952

P577

Q35557813-A3650A78-CBF3-4EAE-AB4C-3334086C221D

P5875

Q35557813-09E685F7-E502-4672-8EB8-1094FB7314C5

P6179

Q35557813-EE14C449-D6EB-497C-9F4B-E08612E41094

P698

Q35557813-E7258878-8A7F-4A0A-8EA8-03ECC680C868

P921

Q35557813-19E69369-E3B3-4207-9AD4-8D243B3AA422

P932

Q35557813-2E09E298-A08A-46D7-B45E-E4ADB65C475C

P356

P1433

Arthritis Research and Therapy

P1476

High mobility group box 1 (HMG ...... systemic lupus erythematosus.

@en

P2093

Deena A Abdulahad

http://www.w3.org/2001/XMLSchema#string

Johanna Westra

http://www.w3.org/2001/XMLSchema#string

Johannes Bijzet

http://www.w3.org/2001/XMLSchema#string

Marc Bijl

http://www.w3.org/2001/XMLSchema#string

Pieter C Limburg

http://www.w3.org/2001/XMLSchema#string

P2860

A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages

DAMPs, PAMPs and alarmins: all we need to know about danger

Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE

Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-α and TNF-α in systemic lupus erythematosus.

Immunoglobulin and complement deposition in skin of rheumatoid arthritis and systemic lupus erythematosus patients

Acute interstitial nephritis with immune complex deposition and MHC class II antigen presentation along the tubular basement membrane.

High-mobility group box-1 protein (HMGB1) is increased in antineutrophilic cytoplasmatic antibody (ANCA)-associated vasculitis with renal manifestations

High-mobility group box-1 protein promotes granulomatous nephritis in adenine-induced nephropathy.

P2888

P304

R71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR3332

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Cees G M Kallenberg

P577

2011-05-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51104366

http://www.w3.org/2001/XMLSchema#string

P6179

1039084446

http://www.w3.org/2001/XMLSchema#string

P698

21548924

http://www.w3.org/2001/XMLSchema#string

P921

P932

3218880

http://www.w3.org/2001/XMLSchema#string